{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:56:46Z","timestamp":1794855406080,"version":"4.9.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.neuropharm.2024.109836","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T20:20:24Z","timestamp":1704486024000},"page":"109836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents"],"prefix":"10.1016","volume":"246","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6269-5552","authenticated-orcid":false,"given":"Susan M.","family":"O'Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-1048","authenticated-orcid":false,"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P.","family":"Street","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-2423","authenticated-orcid":false,"given":"Bernard L.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2114-8242","authenticated-orcid":false,"given":"Jonathan B.","family":"Baell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurul","family":"Quazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9540-9455","authenticated-orcid":false,"given":"Dharam","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Poiraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Huyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Andriambeloson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol B.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuropharm.2024.109836_bib2","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1152\/jn.2001.86.6.3043","article-title":"Nicotinic acetylcholine receptor alpha7 and alpha4beta2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus","volume":"86","author":"Alkondon","year":"2001","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib3","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0022-3565(25)21311-8","article-title":"Mapping the location of functional nicotinic and gamma-aminobutyric acid A receptors on hippocampal neurons","volume":"279","author":"Alkondon","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109836_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(98)00880-4","article-title":"alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices","volume":"810","author":"Alkondon","year":"1998","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2024.109836_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(00)00006-6","article-title":"alpha7 nicotinic acetylcholine receptors and modulation of GABAergic synaptic transmission in the hippocampus","volume":"393","author":"Alkondon","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109836_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1460-9568.2008.06077.x","article-title":"Allosteric modulation of alpha 7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission","volume":"27","author":"Arnaiz-Cot","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109836_bib7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2174\/156802611795371350","article-title":"GABAA receptor subtype-selective modulators. I. \u03b12\/\u03b13-selective agonists as non-sedating anxiolytics","volume":"11","author":"Atack","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.109836_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-540-69248-5_7","article-title":"Molecular and cellular mechanisms of action of nicotine in the CNS","volume":"192","author":"Barik","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109836_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","article-title":"Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review","volume":"33","author":"Berger","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.109836_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2022.107660","article-title":"Role of noradrenergic arousal for fear extinction processes in rodents and humans","volume":"194","author":"Bierwirth","year":"2022","journal-title":"Neurobiol. Learn. Mem."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2024.109836_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109836_bib12","first-page":"178","article-title":"Neurobiological investigations into the role of cholecystokinin in panic disorder","volume":"18","author":"Bradwejn","year":"1993","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109836_bib13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.mp.4001852","article-title":"Treatment-resistant anxiety disorders","volume":"11","author":"Bystritsky","year":"2006","journal-title":"Mol. Psychiatr."},{"issue":"Pt3","key":"10.1016\/j.neuropharm.2024.109836_bib77","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bst0320529","article-title":"The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function","volume":"32","author":"Connolly","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2024.109836_bib14","series-title":"Neuropsychopharmacology: the Fifth Generation of Progress","year":"2002"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nprot.2006.20","article-title":"Digging and marble burying in mice: simple methods for in vivo identification of biological impacts","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/09658211.2014.886704","article-title":"Fear conditioning and extinction in anxiety- and depression-prone persons","volume":"23","author":"Dibbets","year":"2015","journal-title":"Memory"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109836_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mol.108.046623","article-title":"Presynaptic alpha 7- and beta 2-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms","volume":"74","author":"Dickinson","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109836_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1037\/0735-7044.112.6.1423","article-title":"Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus","volume":"112","author":"File","year":"1998","journal-title":"Behav. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109836_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002210050546","article-title":"Major biological actions of CCK--a critical evaluation of research findings","volume":"123","author":"Fink","year":"1998","journal-title":"Exp. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0166-4328(97)00214-3","article-title":"A new continuous alternation task in T-maze detects hippocampal dysfunction in mice. A strain comparison and lesion study","volume":"95","author":"Gerlai","year":"1998","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00001756-199303000-00017","article-title":"Evidence for a dissociation between benzodiazepine withdrawal signs","volume":"4","author":"Goudie","year":"1993","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109836_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002130050282","article-title":"Behavioral profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs","volume":"131","author":"Griebel","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(91)90156-K","article-title":"Evidence that CCKB receptors mediate the regulation of exploratory behavior in the rat","volume":"193","author":"Harro","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"7778","key":"10.1016\/j.neuropharm.2024.109836_bib27","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic-adrenergic hypothesis of mania and depression","volume":"2","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.neuropharm.2024.109836_bib28","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/jm040219e","article-title":"Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations","volume":"48","author":"Jensen","year":"2005","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.292.3.338","article-title":"Antidepressants and the risk of suicidal behaviors","volume":"292","author":"Jick","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm967","article-title":"Modifying quinolone antibiotics yields new anxiolytics","volume":"10","author":"Johnstone","year":"2004","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109836_bib31","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1046\/j.1471-4159.2000.0752409.x","article-title":"Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release","volume":"75","author":"Kenny","year":"2000","journal-title":"J. Neurochem."},{"issue":"27","key":"10.1016\/j.neuropharm.2024.109836_bib32","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1523\/JNEUROSCI.23-27-09024.2003","article-title":"Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons","volume":"23","author":"Khiroug","year":"2003","journal-title":"J. Neurosci."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2024.109836_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1113\/jphysiol.2006.118232","article-title":"Functional somato-dendritic alpha7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex","volume":"576","author":"Klein","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2024.109836_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nlm.2015.11.021","article-title":"High affinity \u03b14\u03b22 nicotinic receptors mediate the impairing effects of acute nicotine on contextual fear extinction","volume":"128","author":"Kutlu","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109836_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1755-5949.2008.00054.x","article-title":"TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity","volume":"14","author":"Lippiello","year":"2008","journal-title":"CNS Neurosci Ther. Winter"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1460-9568.2009.06613.x","article-title":"alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex","volume":"29","author":"Livingstone","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/npp.2015.180","article-title":"Stress and fear extinction","volume":"41","author":"Maren","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/npp.2008.173","article-title":"Removing obstacles in neuroscience drug discovery: the future path for animal models","volume":"34","author":"Markou","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109836_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0306-4530(97)00079-6","article-title":"Response of the hypothalamo-pituitary-adrenal axis to nicotine","volume":"23","author":"Matta","year":"1998","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pbb.2008.04.003","article-title":"Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions","volume":"90","author":"Micale","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109836_bib40","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1523\/JNEUROSCI.1941-20.2020","article-title":"Prefrontal \u03b17nAChR signaling differentially modulates afferent drive and trace fear conditioning behavior in adolescent and adult rats","volume":"41","author":"Miguelez Fern\u00e1ndez","year":"2021","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109836_bib41","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1073\/pnas.1219731110","article-title":"Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior","volume":"110","author":"Mineur","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109836_bib43","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/bph.13769","article-title":"Hippocampal \u03b17 nicotinic ACh receptors contribute to modulation of depression-like behavior in C57BL\/6J mice","volume":"175","author":"Mineur","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.109836_bib45","unstructured":"NCT04951076 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04951076?term=bnc210&draw=2&rank=1."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1037\/1064-1297.10.1.18","article-title":"Anxiolytic effects of mecamylamine in two animal models of anxiety","volume":"10","author":"Newman","year":"2002","journal-title":"Exp. Clin. Psychopharmacol"},{"issue":"19","key":"10.1016\/j.neuropharm.2024.109836_bib47","doi-asserted-by":"crossref","first-page":"8059","DOI":"10.1073\/pnas.0701321104","article-title":"Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators","volume":"104","author":"Ng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2024.109836_bib49","series-title":"Poster P.4.a.005","article-title":"Pharmacodynamic effects of single oral doses of the novel anxiolytic compound BNC210 in healthy male volunteers","author":"O'Connor","year":"2011"},{"key":"10.1016\/j.neuropharm.2024.109836_bib50","series-title":"Poster 684.15\/GG27, Tuesday November 15th (PM) at Society for Neuroscience","article-title":"The novel compound BNC210 partially reduces Panic Symptom Scale scores in a model of CCK-4 induced panic in healthy volunteers","author":"O'Connor","year":"2011"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41398-020-01141-5","article-title":"Cholinergic modulation of disorder-relevant human defensive behavior in generalised anxiety disorder","volume":"11","author":"Perkins","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109836_bib53","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/00001756-200207020-00006","article-title":"Effect of nicotine and nicotinic receptors on anxiety and depression","volume":"13","author":"Picciotto","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2024.109836_bib55","series-title":"Chapter I.C in Central Nervous System (CNS) Safety Pharmacology Studies in Drug Discovery and Evaluation","author":"Porsolt","year":"2006"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109836_bib56","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","article-title":"EVP-6124, a novel and selective \u03b17 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of \u03b17 nicotinic acetylcholine receptors","volume":"62","author":"Prickaerts","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2024.109836_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109836_bib58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-008-1281-x","article-title":"Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release","volume":"203","author":"Quarta","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-006-0568-z","article-title":"The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice","volume":"189","author":"Rabenstein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.109836_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3940(94)90681-5","article-title":"Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety","volume":"172","author":"Rex","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib61","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neulet.2011.09.035","article-title":"Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice","volume":"504","author":"Roni","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jnnp.13.1.47","article-title":"The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis","volume":"13","author":"Rowntree","year":"1950","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109836_bib63","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0091-3057(01)00715-8","article-title":"Nicotinic-serotonergic interactions in brain and behavior","volume":"71","author":"Seth","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.109836_bib64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2014.12.004","article-title":"Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders","volume":"149","author":"Singewald","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"19","key":"10.1016\/j.neuropharm.2024.109836_bib65","doi-asserted-by":"crossref","first-page":"E2543","DOI":"10.1073\/pnas.1418289112","article-title":"Molecular blueprint of allosteric binding sites in a homologue of the agonist-binding domain of the \u03b17 nicotinic acetylcholine receptor","volume":"112","author":"Spurny","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109836_bib66","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bcp.2011.06.010","article-title":"Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25-year career","volume":"82","author":"Terry","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109836_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0028-3908(02)00391-X","article-title":"Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors","volume":"44","author":"Tucci","year":"2003","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib68","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.110.171892","article-title":"RG3487, a novel nicotinic \u03b17 receptor partial agonist, improves cognition and sensorimotor gating in rodents","volume":"336","author":"Wallace","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109836_bib69","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/jpet.119.263483","article-title":"Pharmacological characterization of the novel and selective \u03b17 nicotinic acetylcholine receptor-positive allosteric modulator BNC375","volume":"373","author":"Wang","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109836_bib70","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.biopsych.2019.12.013","article-title":"Cholinergic modulation of disorder-relevant neural circuits in generalized anxiety disorder","volume":"87","author":"Wise","year":"2020","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109836_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173321","article-title":"The imidazodiazepine, KRM-II-81: an example of a newly emerging generation of GABAkines for neurological and psychiatric disorders","volume":"213","author":"Witkin","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.109836_bib72","series-title":"Nicotinic Acetylcholine Receptors TOCRIS REVIEW","author":"Wonnacott","year":"2014"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109836_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-022-00012-3","article-title":"Ketamine treatment for depression: a review","volume":"2","author":"Yavi","year":"2022","journal-title":"Discov Ment Health"},{"issue":"38","key":"10.1016\/j.neuropharm.2024.109836_bib74","doi-asserted-by":"crossref","first-page":"14686","DOI":"10.1073\/pnas.0804372105","article-title":"Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site","volume":"105","author":"Young","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109836_bib75","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41593-021-00949-8","article-title":"Fear learning induces \u03b17-nicotinic acetylcholine receptor-mediated astrocytic responsiveness that is required for memory persistence","volume":"24","author":"Zhang","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"24","key":"10.1016\/j.neuropharm.2024.109836_bib76","doi-asserted-by":"crossref","first-page":"15258","DOI":"10.1021\/acs.jmedchem.0c01304","article-title":"Drug development in channelopathies: allosteric modulation of ligand-gated and voltage-gated ion channels","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:26:36Z","timestamp":1758439596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":71,"alternative-id":["S0028390824000029"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109836","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109836"}}